Article
Azole-resistant and -susceptible Aspergillus fumigatus isolates show comparable fitness and azole treatment outcome in immunocompetent mice.
Medical mycology - 1 Aug 2018
Lackner Michaela, Rambach Günter, Jukic Emina, Sartori Bettina, Fritz Josef, Seger Christoph, Hagleitner Magdalena, Speth Cornelia, Lass-Flörl Cornelia
Abstract excerpt
No data are available on the in vivo impact of infections with in vitro azole-resistant Aspergillus fumigatus in immunocompetent hosts. Here, the aim was to investigate fungal fitness and treatment response in immunocompetent mice infected with A. fumigatus (parental strain [ps]) and isogenic mutants carrying either the mutation M220K or G54W (cyp51A). The efficacy of itraconazole (ITC) and posaconazole (PSC) was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
